カテゴリー： 世界, 医療/バイオ, Grand View Research

世界のアレルギー診断・治療市場2023-2030：製品別（器具、消耗品）、アレルゲン種類別（食品、吸入、薬剤）、検査種類別、薬剤クラス別、地域別

【英語タイトル】Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Allergen Type (Food, Inhaled, Drug), By Test Type, By Drug Class, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN008）・商品コード：GRV23JUN008
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月4日
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界のアレルギー診断・治療市場規模が、予測期間中（2023年～2030年）に年平均6.6％増加し、2030年までに488.6億ドルへ達すると見込まれています。本調査書では、アレルギー診断・治療の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、薬剤クラス別（抗ヒスタミン剤、充血緩和剤、副腎皮質ホルモン剤、肥満細胞安定剤、その他）分析、アレルゲン種類別（食品、吸入、薬剤、その他）分析、製品別（器具、消耗品、サービス）分析、検査種類別（インビボ検査、インビトロ検査）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、R-Biopharm AG、EUROIMMUN Medizinische Labordiagnostika AG、DASIT Group SPA、AESKU.GROUP GmbH、bioMérieux、Danaherなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界アレルギー診断・治療の市場規模：薬剤クラス別
- 抗ヒスタミン剤の市場規模
- 充血緩和剤の市場規模
- 副腎皮質ホルモン剤の市場規模
- 肥満細胞安定剤の市場規模
- その他アレルギー診断・治療の市場規模
・世界アレルギー診断・治療の市場規模：アレルゲン種類別
- 食品アレルゲンにおける市場規模
- 吸入アレルゲンにおける市場規模
- 薬剤アレルゲンにおける市場規模
- その他アレルゲンにおける市場規模
・世界アレルギー診断・治療の市場規模：製品別
- 器具の市場規模
- 消耗品の市場規模
- サービスの市場規模
・世界アレルギー診断・治療の市場規模：検査種類別
- インビボ検査における市場規模
- インビトロ検査における市場規模
・世界アレルギー診断・治療の市場規模：地域別
- 北米のアレルギー診断・治療市場規模
- ヨーロッパのアレルギー診断・治療市場規模
- アジア太平洋のアレルギー診断・治療市場規模
- 中南米のアレルギー診断・治療市場規模
- 中東・アフリカのアレルギー診断・治療市場規模
・競争状況

アレルギー診断・治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のアレルギー診断・治療市場規模は、2023年から2030年にかけて年平均成長率6.6%で推移し、2030年には488億6000万米ドルに達する見込みです。アレルギー疾患の罹患率の増加は、高度な治療薬への需要と相まって、今後数年間の市場成長を促進すると予想されています。米国アレルギー喘息免疫学会（AAAAI）が発表した推計によると、アレルギー性鼻炎は世界人口の約10〜30％が罹患しており、世界的にアレルギー治療薬の採用に影響を与えています。

治療成績の向上や疾病管理のための人工知能技術の使用など、技術的に高度な製品の統合が進んでいることは、開業医の意思決定プロセスに役立っています。さらに、鼻炎などのアレルギーを診断するためのmHealthアプリの採用が増加していることも、市場を押し上げると予想されます。例えば、MASK-Airアプリはアレルギー性鼻炎に特化しています。

モノクローナル抗体は、その高い有効性、長期にわたる忍容性、安全性により、特定のアレルギーの懸念を払拭する新しい治療法の開発に貢献すると予想されます。そのため、主要企業は、特にモノクローナル抗体のような選択的な標的を対象とした、標的特異的なメカニズムで設計された新規かつ効果的な生物学的製剤を開発しています。さらに、アレルギー疾患に対する非常に重要なモノクローナル抗体の一貫した製品承認は、成長範囲を拡大すると予想されます。

抗免疫グロブリンE（IgE）抗体、サイトカインモジュレーター、DNAワクチン接種などの新しい治療法がアレルギー疾患の治療に用いられています。オマリズマブは組換えヒト化IgG1モノクローナル抗IgE抗体で、アレルギー性の慢性蕁麻疹や喘息の治療に使用されます。2021年4月、ジェネンテック（ロシュ・グループ）は、自己注射用プレフィルドシリンジが、慢性特発性蕁麻疹アレルギー性喘息、鼻ポリープを適応症とするゾレア（オマリズマブ）のFDA承認を米国で取得したと発表しました。

アレルギー診断・治療市場は、存在感が強いMerck & Co., Inc.、Thermo Fisher Scientific, Inc.、Abbott、Pfizer, Inc. などの注目企業により、ほどほどの競争状況となっています。これらの企業は、能力を高め、製品ポートフォリオを拡大し、能力を向上させるために様々な取り組みを行っています。

アレルギー診断・治療市場レポートハイライト

– 2022年のアレルギー診断・治療市場では、消耗品製品分野が最大のシェアを占めました。感度、精度、検出速度の向上につながるMeDALLアレルゲンチップを含む製品の登場が市場成長を促進すると予測されます。

– 薬物アレルギー分野は、治療選択肢の増加や患者の薬物アレルギーに対する意識の高まりにより、高成長が期待されます。

– 喘息、鼻炎、アレルギー性結膜炎などのアレルギー発症率の増加、世界的なアレルギー検査需要の増加により、2022年には試験管内検査が最も高いシェアを占めています。

– 2022年の薬物クラス別セグメントではエピネフリンが優勢です。主要企業による費用対効果の高いエピネフリン自己注射器の導入は、市場成長を大幅に増大させると予想されます。

– 2022年のアレルギー診断・治療市場は、アレルギー治療に関連する高い可能性に対する理解の高まりにより、北米が支配的となり、このため、米国を拠点とする企業はこれらの医薬品の開発にかなりの投資を行うようになりました。

– アジア太平洋地域は、特に喘息、慢性咳嗽、食物アレルギーの罹患率が上昇していることから、今後かなりの成長が見込まれます。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.5.1.2. Approach 2: Country-wise market estimation using a bottom-up approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Allergy Diagnostics & Therapeutics Market – Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of allergies
3.2.1.2. Advancements in technology and launch of new products
3.2.1.3. High adoption of immunotherapy drugs
3.2.2. Market Restraint Analysis
3.2.2.1. Low adoption and penetration in developing countries due to the high cost of technology
3.2.2.2. Lack of allergen standardization
3.3. Business Environmental Tools Analysis: Allergy Diagnostics & Therapeutics Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Pipeline Analysis
Chapter 4. Allergy Diagnostics & Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Allergy Diagnostics & Therapeutics Market, By Drug Class: Key Takeaways
4.2. Allergy Diagnostics & Therapeutics Market: Drug Class Movement & Market Share Analysis, 2022 & 2030
4.3. Antihistamines
4.3.1. Global Antihistamines Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4. Decongestants
4.4.1. Global Decongestants Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.5. Corticosteroids
4.5.1. Global Corticosteroids Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.6. Mast Cell Stabilizers
4.6.1. Global Mast Cell Stabilizers Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.7. Leukotriene Inhibitors
4.7.1. Global Leukotriene Inhibitors Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.8. Nasal Anti-cholinergic
4.8.1. Global Nasal Anti-cholinergic Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.9. Immuno-modulators
4.9.1. Global Immuno-modulators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.10. Epinephrine
4.10.1. Global Epinephrine Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.11. Immunotherapy
4.11.1. Global Immunotherapy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis
5.1. Allergy Diagnostics & Therapeutics Market, By Allergen Type: Key Takeaways
5.2. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement & Market Share Analysis, 2022 & 2030
5.3. Food
5.3.1. Global Food Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.2. Dairy Products
5.3.2.1. Global Dairy Products Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.3. Poultry Product
5.3.3.1. Global Poultry Products Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.4. Tree Nuts
5.3.4.1. Global Tree Nuts Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.5. Peanuts
5.3.5.1. Global Peanut Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.6. Shellfish
5.3.6.1. Global Shellfish Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.7. Wheat
5.3.7.1. Global Wheat Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.8. Soy
5.3.8.1. Global Soy Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3.9. Other Food Allergens
5.3.9.1. Global Food Allergens Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.4. Inhaled
5.4.1. Global Inhaled Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.5. Drug
5.5.1. Global Drug Allergy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.6. Others allergen types
5.6.1. Global Other allergen types Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Allergy Diagnostics Market: Product Estimates & Trend Analysis
6.1. Allergy Diagnostics Market, By Product: Key Takeaways
6.2. Allergy Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
6.3. Instruments
6.3.1. Global Instruments Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4. Consumables
6.4.1. Global Consumables Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5. Services
6.5.1. Global Services Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis
7.1. Allergy Diagnostics Market, By Test Type: Key Takeaways
7.2. Allergy Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
7.3. In Vivo tests
7.3.1. Global In Vivo Tests Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3.2. Skin Prick Test
7.3.2.1. Global Skin Prick Test Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3.3. Intradermal Test
7.3.3.1. Global Intradermal Test Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3.4. Patch Test
7.3.4.1. Global Patch Test Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4. In Vitro tests
7.4.1. Global In Vitro Tests Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8. Allergy Diagnostics & Therapeutics Market: Regional Estimates & Trend Analysis
8.1. Allergy Diagnostics & Therapeutics Market: Regional Movement Analysis, 2022 & 2030
8.2. North America
8.2.1. North America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Prevalence Insights
8.2.2.4. Regulatory Framework
8.2.2.5. Reimbursement Structure
8.2.2.6. U.S. Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Prevalence Insights
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Structure
8.2.3.6. Canada Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Prevalence Insights
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Structure
8.3.2.6. UK Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Prevalence Insights
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Structure
8.3.3.6. Germany Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Prevalence Insights
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Structure
8.3.4.6. France Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Prevalence Insights
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Structure
8.3.5.6. Italy Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Prevalence Insights
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Structure
8.3.6.6. Spain Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Prevalence Insights
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Structure
8.3.7.6. Denmark Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Prevalence Insights
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Structure
8.3.8.6. Sweden Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Prevalence Insights
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Structure
8.3.9.6. Norway Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Prevalence Insights
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Structure
8.4.2.6. Japan Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Prevalence Insights
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Structure
8.4.3.6. China Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Prevalence Insights
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Structure
8.4.4.6. India Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Prevalence Insights
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Structure
8.4.5.6. Australia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Prevalence Insights
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Structure
8.4.6.6. Thailand Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Prevalence Insights
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Structure
8.4.7.6. South Korea Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Prevalence Insights
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Structure
8.5.2.6. Brazil Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Prevalence Insights
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Structure
8.5.3.6. Mexico Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Prevalence Insights
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Structure
8.5.4.6. Argentina Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6. Middle East & Africa
8.6.1. Middle East & Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Prevalence Insights
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Structure
8.6.2.6. South Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Prevalence Insights
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Structure
8.6.3.6. Saudi Arabia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Prevalence Insights
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Structure
8.6.4.6. UAE Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Prevalence Insights
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Structure
8.6.5.6. Kuwait Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Share Analysis, 2022
9.3. Strategy Mapping
9.4. Company Profiles/Listing
9.4.1. R-Biopharm AG
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. EUROIMMUN Medizinische Labordiagnostika AG
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. DASIT Group SPA
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. AESKU.GROUP GmbH
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. bioMérieux
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Danaher
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Thermo Fisher Scientific, Inc
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Stallergenes Greer
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Minaris Medical America, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Siemens Healthcare GmbH
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Omega Diagnostics Group PLC
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. HYCOR Biomedical
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. Lincoln Diagnostics, Inc.
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Alcon
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. HOB Biotech Group Corp., Ltd.
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. AbbVie Inc.
9.4.16.1. Overview
9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. Allergy Therapeutics
9.4.17.1. Overview
9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Sanofi
9.4.18.1. Overview
9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. Pfizer Inc.
9.4.19.1. Overview
9.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. Teva Pharmaceutical Industries Ltd.
9.4.20.1. Overview
9.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiatives
9.4.21. Sun Pharmaceutical Industries Ltd.
9.4.21.1. Overview
9.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.21.3. Product Benchmarking
9.4.21.4. Strategic Initiatives
9.4.22. GSK plc
9.4.22.1. Overview
9.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.22.3. Product Benchmarking
9.4.22.4. Strategic Initiatives
9.4.23. F. Hoffmann-La Roche Ltd.
9.4.23.1. Overview
9.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.23.3. Product Benchmarking
9.4.23.4. Strategic Initiatives
9.4.24. Merck & Co., Inc.
9.4.24.1. Overview
9.4.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.24.3. Product Benchmarking
9.4.24.4. Strategic Initiatives
9.4.25. Astellas Pharma Inc.
9.4.25.1. Overview
9.4.25.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.25.3. Product Benchmarking
9.4.25.4. Strategic Initiativesa

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2018 - 2030 (USD Million)
TABLE 4 Global Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 6 Global Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 7 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 8 Global Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 9 Global Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 10 North America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
TABLE 11 North America Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 12 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 13 North America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 14 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 15 North America Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 16 North America Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 17 U.S. Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 18 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 19 U.S. Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 20 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 21 U.S. Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 22 U.S. Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 23 Canada Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 24 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 25 Canada Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 26 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 27 Canada Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 28 Canada Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 29 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
TABLE 30 Europe Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 31 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 32 Europe Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 33 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 34 Europe Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 35 Europe Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 36 UK Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 37 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 38 UK Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 39 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 40 UK Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 41 UK Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 42 Germany Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 43 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 44 Germany Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 45 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 46 Germany Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 47 Germany Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 48 France Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 49 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 50 France Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 51 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 52 France Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 53 France Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 54 Italy Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 55 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 56 Italy Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 57 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 58 Italy Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 59 Italy Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 60 Spain Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 61 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 62 Spain Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 63 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 64 Spain Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 65 Spain Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 66 Denmark Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 67 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 68 Denmark Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 69 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 70 Denmark Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 71 Denmark Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 72 Sweden Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 73 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 74 Sweden Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 75 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 76 Sweden Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 77 Sweden Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 78 Norway Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 79 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 80 Norway Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 81 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 82 Norway Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 83 Norway Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 84 APAC Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
TABLE 85 APAC Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 86 APAC Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 87 APAC Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 88 APAC Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 89 APAC Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 90 APAC Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million
TABLE 91 Japan Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 92 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 93 Japan Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 94 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 95 Japan Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 96 Japan Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 97 China Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 98 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 99 China Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 100 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 101 China Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 102 China Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 103 India Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 104 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 105 India Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 106 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 107 India Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 108 India Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 109 Australia Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 110 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 111 Australia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 112 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 113 Australia Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 114 Australia Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 115 South Korea Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 116 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 117 South Korea Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 118 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 119 South Korea Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 120 South Korea Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 121 Thailand Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 122 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 123 Thailand Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 124 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 125 Thailand Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 126 Thailand Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 127 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
TABLE 128 Latin America Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 129 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 130 Latin America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 131 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 132 Latin America Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 133 Latin America Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 134 Brazil Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 135 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 136 Brazil Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 137 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 138 Brazil Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 139 Brazil Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 140 Mexico Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 141 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 142 Mexico Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 143 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 144 Mexico Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 145 Mexico Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 146 Argentina Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 147 Argentina Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 148 Argentina Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 149 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 150 Argentina Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 151 Argentina Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 152 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
TABLE 153 MEA Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 154 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 155 MEA Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 156 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 157 MEA Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 158 MEA Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 159 South Africa Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 160 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 161 South Africa Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 162 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 163 South Africa Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 164 South Africa Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 165 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 166 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 167 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 168 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 169 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 170 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 171 UAE Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 172 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 173 UAE Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 174 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 175 UAE Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 176 UAE Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
TABLE 177 Kuwait Allergy Diagnostics & Therapeutics Market, By Product, 2018 - 2030 (USD Million)
TABLE 178 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
TABLE 179 Kuwait Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
TABLE 180 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
TABLE 181 Kuwait Allergy Diagnostics & Therapeutics Market, By In vivo test type, 2018 - 2030 (USD Million)
TABLE 182 Kuwait Allergy Diagnostics & Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)

★調査レポート[世界のアレルギー診断・治療市場2023-2030：製品別（器具、消耗品）、アレルゲン種類別（食品、吸入、薬剤）、検査種類別、薬剤クラス別、地域別] (コード：GRV23JUN008)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアレルギー診断・治療市場2023-2030：製品別（器具、消耗品）、アレルゲン種類別（食品、吸入、薬剤）、検査種類別、薬剤クラス別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアレルギー診断＆治療薬市場2023-2030：製品別（機器、消耗品、サービス）、アレルゲンタイプ別（食品、吸入、医薬品、その他）、検査種類別（in vivo検査、in vitro検査）、薬剤クラス別（抗ヒスタミン薬、鬱血除去薬、副腎皮質ステロイド薬、肥満細胞安定化薬、ロイコトリエン阻害薬、経鼻抗コリン薬、その他）、地域別
  • 世界の炎症性腸疾患（IBD）治療市場2023-2030：種類別（クローン病、潰瘍性大腸炎）、薬剤クラス別、投与経路別、流通チャネル別、地域別
  • 世界のアレルギー診断・治療薬市場2024-2030：種類別（診断薬、治療薬）、アレルゲンタイプ別（食品、吸入、薬剤）、検査タイプ別、地域別
  • 世界の大腸がん治療薬市場2023-2030：薬剤クラス別（化学療法、免疫療法）、地域別（北米、アジア太平洋、中南米、ヨーロッパ）
  • 世界のピーナッツアレルギー治療薬市場2024-2030：薬剤クラス別（抗ヒスタミン薬、エピネフリン）、投与経路別、流通チャネル別、地域別
  • 世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別
  • 世界のHIV診断市場2023-2030：製品別（消耗品、機器）、検査種類別（抗体検査、ウイルス負荷検査）、モード別（自己検査、研究所ベース）、エンドユーザー別、地域別
  • 世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別
  • 世界の多形膠芽腫治療市場2023-2030：治療別（放射線療法、免疫療法）、薬剤クラス別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆